fda drug shortages tirzepatide zepbound shortage status 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these FDA approves weight-loss drug Zepbound

GLP-1 (glucagon-like peptide-1) medications, including compounded versions like semaglutide, were originally developed for diabetes management, but they have become a breakthrough treatment for weight loss

According to TrimRx's published materials, the platform states that licensed providers review each intake independently

It addresses the neurological component while BPC-157 and TB-500 address structural issues

Conversely, a cell with high Glutathione and low NAD+ is like a brand new, perfectly clean factory with no power

Importantly, weight loss continues in the months after starting treatment as the dose escalates, with most men seeing noticeable changes within 812 weeks